Trial intelligence / Profile preview

Calfactant in Direct ARDS

NCT00682500Phase 3Terminated

Sponsor
Pneuma Respiratory
Start
May 2008
Primary completion
Dec 2010
Modality
Recombinant Proteins and Enzymes
Countries
6
01

Overview

A Phase 3 trial of calfactant in acute respiratory distress syndrome (ARDS), sponsored by Pneuma Respiratory. Started May 2008; status: terminated.

02

Drugs

calfactant
03

Conditions

acute respiratory distress syndrome (ARDS)

Beyond the preview

Go deeper on NCT00682500.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00682500.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call